These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Monitoring direct thrombin inhibitors with a plasma diluted thrombin time. Love JE; Ferrell C; Chandler WL Thromb Haemost; 2007 Jul; 98(1):234-42. PubMed ID: 17598018 [TBL] [Abstract][Full Text] [Related]
27. The Changing Landscape of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation: Use of the Direct Thrombin Inhibitors. Neunert C; Chitlur M; van Ommen CH Front Med (Lausanne); 2022; 9():887199. PubMed ID: 35872781 [TBL] [Abstract][Full Text] [Related]
29. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing. Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620 [TBL] [Abstract][Full Text] [Related]
30. Prospective Exploratory Experience With Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation. Ryerson LM; Balutis KR; Granoski DA; Nelson LR; Massicotte MP; Lequier LL; Bauman ME Pediatr Crit Care Med; 2020 Nov; 21(11):975-985. PubMed ID: 32976347 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure. Bissell BD; Gabbard T; Sheridan EA; Baz MA; Davis GA; Ather A Ann Pharmacother; 2022 Apr; 56(4):387-392. PubMed ID: 34323121 [TBL] [Abstract][Full Text] [Related]
32. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors. Van Cott EM; Roberts AJ; Dager WE Semin Thromb Hemost; 2017 Apr; 43(3):270-276. PubMed ID: 28052306 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation. Hamzah M; Jarden AM; Ezetendu C; Stewart R Pediatr Crit Care Med; 2020 Sep; 21(9):827-834. PubMed ID: 32404633 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of direct thrombin inhibitors during a critical heparin shortage. Ji CS; Roberts RJ; Barra ME; Lee H; Rosovsky RP J Thromb Thrombolysis; 2021 Aug; 52(2):662-673. PubMed ID: 33400098 [TBL] [Abstract][Full Text] [Related]
35. Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review. Zhong H; Zhu ML; Yu YT; Li W; Xing SP; Zhao XY; Wang WJ; Gu ZC; Gao Y Front Pharmacol; 2020; 11():565013. PubMed ID: 33013402 [TBL] [Abstract][Full Text] [Related]
36. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation. Seelhammer TG; Brokmeier HM; Hamzah M; Wieruszewski PM Crit Care Med; 2023 May; 51(5):e115-e121. PubMed ID: 36853326 [TBL] [Abstract][Full Text] [Related]
38. Bivalirudin in pediatric patients maintained on extracorporeal life support. Nagle EL; Dager WE; Duby JJ; Roberts AJ; Kenny LE; Murthy MS; Pretzlaff RK Pediatr Crit Care Med; 2013 May; 14(4):e182-8. PubMed ID: 23648880 [TBL] [Abstract][Full Text] [Related]
39. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation. Dager WE; Gosselin RC; Yoshikawa R; Owings JT Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973 [TBL] [Abstract][Full Text] [Related]
40. The dosing and monitoring of argatroban for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a word of caution. Phillips MR; Khoury AI; Ashton RF; Cairns BA; Charles AG Anaesth Intensive Care; 2014 Jan; 42(1):97-8. PubMed ID: 24471670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]